Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesPayablesPreferred SharesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Advanced Oxygen Technologies (AOXY) Current Deferred Revenue (2019 - 2026)

Advanced Oxygen Technologies filings provide 10 years of Current Deferred Revenue readings, the most recent being $3201.0 for Q1 2026.

  • On a quarterly basis, Current Deferred Revenue changed N/A to $3201.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $3201.0, a N/A change, with the full-year FY2025 number at $3281.0, changed N/A from a year prior.
  • Current Deferred Revenue hit $3201.0 in Q1 2026 for Advanced Oxygen Technologies, down from $3283.0 in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $3283.0 in Q4 2025 to a low of $2759.0 in Q3 2022.
  • Median Current Deferred Revenue over the past 3 years was $3105.5 (2022), compared with a mean of $3082.0.
  • The widest YoY moves for Current Deferred Revenue: up 5.41% in 2022, down 15.24% in 2022.
  • Advanced Oxygen Technologies' Current Deferred Revenue stood at $2992.0 in 2022, then grew by 9.73% to $3283.0 in 2025, then decreased by 2.5% to $3201.0 in 2026.
  • The last three reported values for Current Deferred Revenue were $3201.0 (Q1 2026), $3283.0 (Q4 2025), and $3099.0 (Q3 2025) per Business Quant data.